Home | Advocare Pediatric Neurology Associates

Posted on by

Dedicated to Your Child's Neurological Health Advocare Pediatric Neurology Associates is a specialty practice dedicated to the successful diagnosis and treatment of neurological and developmental disorders in children. Our advanced medical staff includes three board certified physicians with more than 75 years of combined experience in pediatric neurology, plus EEG technologists, and medical assistants.

We serve Northern New Jersey with offices in Morristown, Sparta, and Springfield and use state-of-the-art testing and treatment techniques to evaluate childhood language, learning, and attention deficit disorders; developmental disorders such as autism; headaches; and other problems, including childhood seizure disorders, tics, and Tourette's syndrome. Our pediatric neurologists work closely with many of the pediatricians and family physicians in the region.

For your convenience, we offer EEG, 24-hour EEG, long-term monitoring (video EEG), and electrodiagnosis (EMG) of neuromuscular disorders. By providing this comprehensive scope of services in one location, children can develop comfortable relationships with the same doctors and technicians, and parents can spend less time coordinating appointments and visits. We also participate in most managed care programs.

The specialists in Advocare Pediatric Neurology Associates are Sandy P. Waran, M.D., Trevor G. DeSouza, M.D., and Leonid L. Topper, M.D. They are all board certified in pediatric and adult neurology by the American Board of Psychiatry and Neurology, together with the American Board of Pediatrics. Additionally, they are also on staff at Atlantic Health System's Goryeb Children's Hospital, Overlook Hospital and St. Clare's Hospital. They also maintain faculty positions and affiliations at major universities and leading teaching hospitals in the New Jersey/New York metropolitan area.

More:
Home | Advocare Pediatric Neurology Associates

Systemic inflammation during midlife and … – n.neurology.org

Posted on by

Keenan A. Walker

From the Departments of Neurology (K.A.W., R.F.G.) and Epidemiology (R.F.G., A.W., A.L.G., E.S.), Johns Hopkins University, Baltimore, MD; Department of Neurology (D.S.K.), Mayo Clinic, Rochester, MN; Department of Medicine (T.H.M., B.G.W.), Division of Geriatrics, University of Mississippi Medical Center, Jackson.

Rebecca F. Gottesman

From the Departments of Neurology (K.A.W., R.F.G.) and Epidemiology (R.F.G., A.W., A.L.G., E.S.), Johns Hopkins University, Baltimore, MD; Department of Neurology (D.S.K.), Mayo Clinic, Rochester, MN; Department of Medicine (T.H.M., B.G.W.), Division of Geriatrics, University of Mississippi Medical Center, Jackson.

Aozhou Wu

From the Departments of Neurology (K.A.W., R.F.G.) and Epidemiology (R.F.G., A.W., A.L.G., E.S.), Johns Hopkins University, Baltimore, MD; Department of Neurology (D.S.K.), Mayo Clinic, Rochester, MN; Department of Medicine (T.H.M., B.G.W.), Division of Geriatrics, University of Mississippi Medical Center, Jackson.

David S. Knopman

From the Departments of Neurology (K.A.W., R.F.G.) and Epidemiology (R.F.G., A.W., A.L.G., E.S.), Johns Hopkins University, Baltimore, MD; Department of Neurology (D.S.K.), Mayo Clinic, Rochester, MN; Department of Medicine (T.H.M., B.G.W.), Division of Geriatrics, University of Mississippi Medical Center, Jackson.

Alden L. Gross

From the Departments of Neurology (K.A.W., R.F.G.) and Epidemiology (R.F.G., A.W., A.L.G., E.S.), Johns Hopkins University, Baltimore, MD; Department of Neurology (D.S.K.), Mayo Clinic, Rochester, MN; Department of Medicine (T.H.M., B.G.W.), Division of Geriatrics, University of Mississippi Medical Center, Jackson.

Thomas H. Mosley

From the Departments of Neurology (K.A.W., R.F.G.) and Epidemiology (R.F.G., A.W., A.L.G., E.S.), Johns Hopkins University, Baltimore, MD; Department of Neurology (D.S.K.), Mayo Clinic, Rochester, MN; Department of Medicine (T.H.M., B.G.W.), Division of Geriatrics, University of Mississippi Medical Center, Jackson.

Elizabeth Selvin

From the Departments of Neurology (K.A.W., R.F.G.) and Epidemiology (R.F.G., A.W., A.L.G., E.S.), Johns Hopkins University, Baltimore, MD; Department of Neurology (D.S.K.), Mayo Clinic, Rochester, MN; Department of Medicine (T.H.M., B.G.W.), Division of Geriatrics, University of Mississippi Medical Center, Jackson.

B. Gwen Windham

From the Departments of Neurology (K.A.W., R.F.G.) and Epidemiology (R.F.G., A.W., A.L.G., E.S.), Johns Hopkins University, Baltimore, MD; Department of Neurology (D.S.K.), Mayo Clinic, Rochester, MN; Department of Medicine (T.H.M., B.G.W.), Division of Geriatrics, University of Mississippi Medical Center, Jackson.

Read more here:
Systemic inflammation during midlife and ... - n.neurology.org

Residency | Department of Neurology | University of Pittsburgh

Posted on by

The University of Pittsburgh Medical Center (UPMC) Neurology ResidencyProgram continues to attract outstanding physicians from the United States and around the world for state-of-the-art training in the diagnosis and treatment of diseases of the nervous system.

Twenty-eight adult neurology residents train in the four-year program, which begins with one year of internal medicine residency and then proceeds for three years of full-time training in neurology. Resident trainees receive detailed instruction and practical daily experience in the technique of the neurological examination, localization of abnormalities in the nervous system, differential diagnosis, and neurological investigation and therapeutics. For a solid underpinning of basic neuroscience for their clinical training, our residents are taught neuroanatomy, neurophysiology, neurochemistry, neuroradiology, neuropathology, neuropharmacology as well as retrieval and analysis of current medical information. There has been an increased emphasis on the fundamentals and application of evidence-based neurology with a special emphasis on the use of online data for decision-making assistance. Under the direction of an outstanding faculty of attending neurologists, residents assume progressive oversight of patient care during the course of their training.

During the last two years of training, ample elective time allows each resident to develop skills and expertise tailored to his or her particular interests, while the core curriculum assures a high degree of competency in general neurology. The residents are given multiple opportunities to teach via formal lectures, small group conferences, and grand rounds presentations, activities which begin to prepare them for careers in academic neurology. The vast majority of the graduating residents pursue fellowship training and careers in academic neurology.

Continue reading here:
Residency | Department of Neurology | University of Pittsburgh

Neurology – University of Rochester Medical Center

Posted on by

The Department of Neurology is committed to three equally valued and interrelated missions: delivery of quality patient care, generating knowledge from research that will alleviate human suffering through prevention and treatment of disease, and educating physicians in accordance with highest professional standards.

We have an incredible team of neurologists, scientists, nurses, social workers, neuropsychologists, therapists, trainees, and staff who are singularly focused on making a difference in the lives of people with neurological disorders. Whether it is to partner with patients and families to treat symptoms and ease suffering or to be the beacon of hope and optimism for the future, we aim to treat every patient like our only patient. Whether it is to passionately pursue cures for stroke or Parkinsons Disease or to advance our understanding of Alzheimers disease or brain cancer, we seek the truth to benefit others. Whether it is to train physicians to become neurologists or to train neurologists to become scientists, we aim to create an environment of creativity, discovery and fulfillment.

We have completed a strategic planning process and we are well on our way of making our vision become a reality. I invite you to browse these pages to learn about each of our faculty, our clinical programs, our ongoing research efforts, and our training programs. If you would like to contact our department, please email us. We would be happy to answer your questions.

Dr. Robert Holloway

Department of Neurology

All Grand Rounds

Read the rest here:
Neurology - University of Rochester Medical Center

Neurology Conference | Neurology Congress | Neuroscience …

Posted on by

OMICS International organizes conference series all around the world in 2016, here It is our pleasure to invite you to Neurology conference entitled 5th World Congress on Neurology & Therapeutics during March 14-16, 2016 at London, UK.

Neurological disorders are diseases of the brain, spine and the nerves that connect them. There is ample evidence that pinpoints neurological disorders as one of the greatest threats to public health. There are more than 600 diseases of the nervous system, such as Alzheimer's disease, brain tumors, epilepsy, Parkinson's disease, and stroke as well as less familiar ones such as frontotemporal dementia and an estimated 6.8 million people die every year as a result of these disorders there by making it necessary to investigate the unresolved Neurological Disorder.

Track 1: Neuro Genetics

Genes affect the wiring and workings of the brain, which is the authority of all our rides. It is ultimately and solely the genes that give rise to a particular type of protein that may be beneficial or harmful that reflects the need of research in this particular field. 6000 and more emerging genetic disorders account for a significant portion of human disease and conditions. Nearly 4 percent of the approximately 4 million babies born each year have a genetic disease or major birth defect. Around 15,000 Americans are diagnosed to have Huntingtons disease (HD).Keeping the same in view the following sub tracks are designed to enlighten the thoughts related to Huntington's disease (HD) and related genetic disorder, Genetic engineering to overcome neurological problems, The genes as a link between the brain and neurological diseases, Gene defect and diseases, studies on genome wide association and disease diagnostics, sequencing of gene as a tool in determining the abnormal gene loci, Mutation of gene and neuronal migration defect.

Related Conferences of Neuro Genetics

5th World Congress on Neurology and Therapeutics, March 14-16, 2016 London, UK, International Conference on Neuro Genentics, June 6-7, 2016,London, UK , 6th World Neurological Conference May 19-21, 2016 San Antonio, USA, 2nd International Conference on Neurological Disorders and Stroke, April 28-30, 2016 Dubai, UAE, 2nd International Conference on Brain Disorders and Therapeutics October 17-29, 2016 Chicago, USA , Neuro Informatics, Alicantae, Spain, 12th Congress of the European Association of Neuro-Oncology , Germany, 9th International Symposium on Neuroprotection and Neurorepair 2016,Germany, 12th Congress of the European Association of Neuro-Oncology , Germany.

Track 2: Neuro Degenerative Disorders and Stroke

Neurodegenation or neuron death is the progressive loss of structure or function of neurons which includes disorders like Alzheimers disease, Parkinsons disease etc. In the United States, near about 60,000 cases of Parkinsons disease are diagnosed per year. The 3rd leading cause of death after cancer and heart disease is Stroke, thereby focusing on the epidemiology of stroke and risk factors. The main classification of stroke is haemorrhage stroke and ischemic stroke. The areas highlighted for discussion in this session are: Motor neuron diseases and Ataxias, Alzheimers Disease, Mechanism and Diagnosis, Novel Insights and Therapeutics for Parkinsons disease and Amyotrophic lateral sclerosis. Further we will discuss more about the various diagnosis procedure, Imaging technique, and acute stroke management.

Related Conferences of Neuro Degenerative Disorders and Stroke

5th World Congress on Neurology and Therapeutics, March 14-16, 2016 London, UK , 2nd International Conference on Neurological Disorders and Stroke, April 28-30, 2016 Dubai, UAE, 2nd International Conference on Brain Disorders and Therapeutics October 17-29, 2016 Chicago, USA, 6th World Neurological Conference May 19-21, 2016 San Antonio, USA, International Conference on Neurorehabilitation, July 21-22, 2016 Brisbane, Australia, 9th International Symposium on Neuroprotection and Neurorepair2016,Germany, 10th FENS Forum of Neuroscience 2016, Copenhagen, Denmark, Society for Neuroscience 2016 Annual, California, USA, EANS2016: 16th European Congress of Neurosurgery , Athens, Greece, National Neurotrauma Society Symposium 2016, Kentucky, USA.

Track 3: Neuropediatrics and Neurorehabilitation

Paediatric neurology evaluates children with disorders of the central and peripheral nervous systems. A large proportion in US population suffers from autism, mental retardation, dyslexia, seizures and other developmental disabilities. Approximately 1,300 U.S children experience severe or fatal brain trauma from child abuse. Epilepsy is the fourth common neurological disorder in the US after migraine, stroke, and Alzheimers disease. So there is a need to take into account, the following diseases to dissertate: congenital hydrocephalus, Autism, Neonatal encephalopathy, Paediatrics tumour, Neurodevelopment disorder, Epilepsy and Child psychological disorders.

Neurorehabilitation is a complex medical process which aims to aid recovery from a nervous system injury. Rehabilitation is an access to reduce brain abscesses thereby increasing the Neural Repair. Neurological rehabilitation program is aimed to create awareness about the neural disorders and its diagnosis. Physiotherapy and remediation is a novel approach that remediates impairments and promotes mobility. Conference on Neurology and Therapeutics is an effort to address all areas towards Neurorehabilitation and Neural Repair.

Related Conferences of Neuropediatrics and Neurorehabilitation

5th World Congress on Neurology and Therapeutics, March 14-16, 2016 London, UK, Pediatric Neurology Conference, September 29-Oct 1, 2016 Valencia, Spain ,International Conference on Neurorehabilitation, July 21-22, 2016 Brisbane, Australia, Autism Conference, May 5-6, 2016 Chicago, USA, 6th World Neurological Conference May 19-21, 2016 San Antonio, USA, 9th World Congress for NeuroRehabilitation, Philadelphia, USA, Autism, ADHD and Developmental Disabilities New Zealand Cruise 2016, Sydney, Australia,10th FENS Forum of Neuroscience 2016, Copenhagen, Denmark, Society for Neuroscience 2016 Annual, California, USA, 9th International Symposium on Neuroprotection and Neurorepair 2016,Germany.

Track 4: Neurosurgery and Neural Circuits

While the topic sounds pretty small, but we needs more speciality and critical care in this discipline. An estimated 69,720 new cases of primary brain tumors are expected to be diagnosed in 2013, that includes both malignant (24,620) and non-malignant (45,100) brain tumors. Basing on the prevalence of diseases, the conference focuses on Post-surgical neuralgias, Brain tumour and metastatis, Oncological neurosurgery, Spine neurosurgery, Neuroanaesthesia and surgery and Vascular malfunctions and surgery . The neurons are organized into ensembles called Anatomical and functional neural circuits. Current researches identify disorders that affect different components of that neural circuit and a set of neural circuits that are critically involved in a specific disorder. Highest incidence rate of primary intracranial tumor was in Europe and the lowest rate in Africa. So it is requisite to enhance our knowledge on Current neurosurgery method.

Related Conferences of Neurosurgery and Neural Circuits

5th World Congress on Neurology and Therapeutics, March 14-16, 2016 London, UK, 6thGlobal Neurologists Annual Meeting onNeurology and Neuro Surgery, August 01-03, 2016 Frankfurt, Germany, International Conference on Neurorehabilitation, July 21-22, 2016 Brisbane, Australia, 2nd International Conference on Neurological Disorders and Stroke, April 28-30, 2016 Dubai, UAE, 6th World Neurological Conference May 19-21, 2016 San Antonio, USA, EANS2016: 16th European Congress of Neurosurgery , Athens, Greece, American Association of Neurological Surgeons (AANS) 2016,Chicago, Illinois, Congress of Neurological Surgeons 2016, San Diego, California. Asian-Australasian Society for Stereotactic and Functional Neurosurgery Meeting 2016, Australia BritSpine 2016, Nottingham,UK.

Track 5: Neuro Infections and Neuroimmunology

Neuroimmunology is a field of neuroscience, combining immune system and the nervous system. The immune system administer defence against these organisms, inefficiency of the same results in Infections. The condition is much worse in developing countries; it has been a significant health problem in Australia. Some 350,000 to 500,000 patients suffer from multiple sclerosis (MS) in the United States .The conference on neurology is a platform to put our heads together and thrash out the cause of Multiple sclerosis and auto immune neuropathies, Neuroimmunological infectious disease, Neuromicrobial disorders and Neurological Lyme diseases, Neuroinflamation, Neuroimmuno genetics. This session also includes to group think the alteration in neuromodulation and psychiatric diseases and the recent Drug development in the field of Neuro immunological disorders.

Related Conferences of Neuro Infections and Neuroimmunology

5th World Congress on Neurology and Therapeutics, March 14-16, 2016 London, UK, 2nd International Conference on Neurological Disorders and Stroke, April 28-30, 2016 Dubai, UAE, 2nd International Conference on Brain Disorders and Therapeutics October 17-29, 2016 Chicago, USA, 6th World Neurological Conference May 19-21, 2016 San Antonio, USA, International Conference on Neurorehabilitation, July 21-22, 2016 Brisbane, Australia, 9th International Symposium on Neuroprotection and Neurorepair2016,Germany, 5th Euro-CNSBasic Course in Neuropathology, 2016,Aachen, Germany, 12th Annual Update Conference on Clinical Neurology and Neurophysiology, Tel Aviv-Yafo, Israel, The 10th World Congress on Controversies in Neurology (CONy) 2016, Lisboa, Portugal, Asian-Australasian Society for Stereotactic and Functional Neurosurgery Meeting 2016, Cairns, Australia.

Track 6: Alzheimers Disease and Dementia

The brain immediately confronts us with its great complexity. Alzheimer's which is a type of Dementia: An Underlying Disease causes problems with memory, behaviour and thinking. As estimated,5.3 million Americans of all ages have Alzheimer's disease in the recent survey. AD is the sixth leading cause of death in the United States and the fifth leading cause of death in Americans of age 65 and older. The etiological factors, other than older age includes genetic susceptibility. so it is important to exchange views on Causes and Prevention of Alzheimers, Alzheimers Disease Diagnosis and Symptoms, Alzheimers Disease Pathophysiology and Disease Mechanisms, Care Practice and Awareness. we are also going to analyse the Alzheimers Disease Imaging , Mechanisms for Treatment and Therapeutic Targets.

Related Conferences of Alzheimers Disease and Dementia

5th World Congress on Neurology and Therapeutics, March 14-16, 2016 London, UK, 4th International Conference Vascular Dementia, June 30 - July 02, 2016 Valencia, Spain, 5th World Congress on Alzheimers Disease & Dementia, September 29-Oct 1, 2016 London, UK, International Conference on Neurorehabilitation, July 21-22, 2016 Brisbane, Australia, 2nd International Conference on Neurological Disorders and Stroke, April 28-30, 2016 Dubai, UAE, 6th World Neurological Conference May 19-21, 2016 San Antonio, USA, 11th World Congress on Brain Injury, 2016, The Hague, The Netherlands, 10th World Congress on Controversies n Neurology (CONy) 2016 Lisbon, Portugal, 31st International Conference of Alzheimer's Disease International, 2016 Budapest, Hungary, Vas Cog: The International Society of Vascular Behavioural and Cognitive Disorders Conference, 2016, Amsterdam, The Netherlands.

Track 7 : Neuromuscular Disorders

Neuromuscular disorders is known to affect the nerves that control the voluntary muscles. One of the causes is the genetic and immune system disorder. More than a million people in the United States are affected by some form of neuromuscular disease, and about 40 percent of them are under age18.Diagnosis includes a multi-step process like muscle biopsy, NCV test, biochemical, genetic test etc. The goal of this session is to understand the origin of spine muscular atropies, Muscular dystrophy, Lambert-Eaton syndrome and other neuromuscular junction disorder. Further there will be an interactive conversation on Spasticy, Hyper reflexia and its prevention. In addition a talk will be deliberated on Is it true that High dose of antibiotics leads to neuromuscular junction mal function and the findings in the field of neuromuscular medicine.

Related Conferences of Neuromuscular Disorders

5th World Congress on Neurology and Therapeutics, March 14-16, 2016 London, UK, 2nd International Conference on Parkinsons Disease and Movement Disorders, November 28-30, 2016 Chicago, USA, 5th World Congress on Alzheimers Disease and Dementia, September 29-Oct 1, 2016 London, UK, 2nd International Conference on Neurological Disorders and Stroke, April 28-30, 2016 Dubai, UAE, 2nd International Conference on Brain Disorders and Therapeutics October 17-29, 2016 Chicago, USA, 3rd Neuromuscular Biology, Disease and Therapy, 2015, Ottawa, Canada, American Association of Neuromuscular and Electrodiagnostic Medicine, Hawaii, USA, Neuromuscular Care Conference, Nottingham, UK, 9th Neuromuscular Translational Research Conference, 2016, Oxford, United Kingdom, Neuromuscular Disorders, 2016, London, UK

Track 8: Brain Engineering and Neuro-computing

What seems astonishing is that engineering techniques like brain engineering, or Neural tissue engineering can be used to understand, repair, replace, enhance, or otherwise exploit the properties of neural systems and Neuro computing is the study of brain function in terms of the information processing properties of the structures that make up the nervous system. current researches in the field of neuro engineering include: Neural imaging and neural networking, Biomolecular therapies in neural regeneration, Neurorobotics, Biological neural networking, Neuro hydrodynamics and clinical treatment, Engineering strategies for repair, Computational clinical neuroscience, biological-neuron modelling, Behaviors of networks and advanced therapies. People will also be enlightened on Advancement in brain computer interface and deep brain stimulation.

Related Conferences of Brain Engineering and Neuro-computing

5th World Congress on Neurology and Therapeutics, March 14-16, 2016 London, UK, International Conference on Neuro Informatics,September 29-October 01, 2016 Valencia, Spain6th World Neurological Conference May 19-21, 2016 San Antonio, USA, International Conference on Neurorehabilitation, July 21-22, 2016 Brisbane, Australia, 2nd International Conference on Brain Disorders and Therapeutics October 17-29, 2016 Chicago, USA, Computational and Systems Neuroscience (Cosyne) 2016, Snowbird. 9th International Symposium on Neuroprotection and Neurorepair 2016,Germany, 10th FENS Forum of Neuroscience 2016, Copenhagen, Denmark, Society for Neuroscience 2016 Annual, California, USA, 3rd International Conference on Heart and Brain Paris, France.

Track 9: Autonomic and Central Nervous System

Autonomic disorders may result from other disorders that damage autonomic nerves or they may occur on their own. Progressive autonomic failure usually becomes apparent in the sixth decade of life. The Working of the central nervous system has proved to be more and more extensive and more and more fundamental as experiment has advanced in examining it. CNS disorder can be either myelopathy or encephalopathy.

Specified disorders to be discussed under this category are: Bipolar disorder, Migraine and Neuropathic pain syndromes, Accessory nerve disorder, Autonomic dysreflexia and neuropathy, CNS disorder and structural defects, Facial nerve paralysis and Meningitis.

Related Conferences of Autonomic and Central Nervous System

5th World Congress on Neurology and Therapeutics, March 14-16, 2016 London, UK, 2nd International Conference on Central Nervous System Disorders and Therapeutics,December 01-02, 2016 Dubai, UAE, International Conference on Neurorehabilitation, July 21-22, 2016 Brisbane, Australia, 2nd International Conference on Brain Disorders and Therapeutics October 17-29, 2016 Chicago, USA, 6th World Neurological Conference May 19-21, 2016 San Antonio, USA, 9th International Symposium on Neuroprotection and Neurorepair 2016,Germany, 5th Euro-CNSBasic Course in Neuropathology, 2016,Aachen, Germany, 12th Annual Update Conference on Clinical Neurology & Neurophysiology, Tel Aviv-Yafo, Israel, The 10th World Congress on Controversies in Neurology (CONy) 2016, Lisboa, Portugal, National Neurotrauma Society Symposium 2016, Kentucky, USA.

Track 10: Neuro Pharmacology

Increase in technology and our understanding of the nervous system has lead to the development of drugs and medicines in the two main branches i.e. molecular and behavioural beyond our imagination that has continued to rise with an increase in drug specificity and sensitivity. current topic to be discussed are New pharmacological approaches for treatment of neural disorders, drug development in cell signalling and synaptic spasticity, and the latest advancement in neuropharmacologcal therapy and drug development in this particular sector. The present conference also aims to educate the researchers on Neuroimmuno pharmacology and Interfearance of pharmacological agents in neural disorder mechanism.

Related Conferences of Neuro Pharmacology

5th World Congress on Neurology and Therapeutics, March 14-16, 2016 London, UK , 5th International Conference on Addiction Research & Therapy ,October 06-08, 2016 Florida, USA, 2nd International Conference on Brain Disorders and Therapeutics October 17-29, 2016 Chicago, USA, 6th World Neurological Conference May 19-21, 2016 San Antonio, USA, International Conference on Neurorehabilitation, July 21-22, 2016 Brisbane, Australia, 9th International Symposium on Neuroprotection and Neurorepair 2016,Germany, 5th Euro-CNSBasic Course in Neuropathology, 2016,Aachen, Germany, 12th Annual Update Conference on Clinical Neurology & Neurophysiology, Tel Aviv-Yafo, Israel, The 10th World Congress on Controversies in Neurology (CONy) 2016, Lisboa, Portugal, Asian-Australasian Society for Stereotactic and Functional Neurosurgery Meeting 2016, Cairns, Australia.

Track 11: Neuro Therapeutics, Diagnostics and Case Studies

Various neurology conferences are held all over the world like world congress of neurology 2015 Chile in order to enhance and empower the knowledge of neuroscience. The 5th International conference on neurology and therapeutics that will be held at London in March 2016, addresses all areas pertinent to this endeavour concentrating on Novel Therapeutics and Diagnostics at the cellular and molecular level. There is a profound increase in the diagnostics procedure and drug discovery in the field of Neurology.

In order to accelerate the discovery of novel diagnostic therapy, the gathering of researchers is encouraged in order to discuss on the theme Stem cells in neurological disorder and treatment, Nerve injury and repair, Sleep disorders and headache, Neurogenesis, and last but not the least new therapeutics evolved for neurological disorders

Related Conferences of Neuro Therapeutics, Diagnostics and Case Studies

5th World Congress on Neurology and Therapeutics, March 14-16, 2016 London, UK, Global Neuroscience Conference, November 07-09, 2016 Melborne, Australia, 6th Global Neurologists Annual Meeting onNeurology and Neuro Surgery, August 01-03, 2016 Frankfurt, Germany, International Conference on Neurorehabilitation, July 21-22, 2016 Brisbane, Australia, 2nd International Conference on Neurological Disorders and Stroke, April 28-30, 2016 Dubai, UAE, 6th World Neurological Conference May 19-21, 2016 San Antonio, USA,9th International Symposium on Neuroprotection and Neurorepair 2016,Germany, 10th FENS Forum of Neuroscience 2016, Copenhagen, Denmark, Society for Neuroscience 2016 Annual, California, USA, EANS2016: , 5th Euro-CNSBasic Course in Neuropathology, 12th Annual Update Conference on Clinical Neurology & Neurophysiology, Tel Aviv-Yafo, Israel.

Track 12: Clinical Neurology and Neuropathic pain

It is admirable to discuss about clinical neuroscience as this focuses on the fundamental mechanisms of diseases and disorders of the brain and central nervous system and seeks to develop new ways of diagnosing such anarchy, leading to the development of novel medication. As per the estimates by the World Health Organization, neural disorders affect over 1 billion people worldwide, constitute 12% of the burden of disease globally, and cause 14% of global annihilation. Neuropathic pain (neuralgia) is a pain that comes from problems with signals from the nerves. It was mainly classified into peripheral neuropathic pain and central neuropathic pain which includes spinal cord injury and central disorders. Pain is a significant public health problem that costs society at least $560-$635 billion annually.Women was more likely to experience pain in comparison to men. According to the recent survey, Chronic Pain affects 47% of USA Adults. The main intent of this session is to understand Complex regional pain syndrome (CRPS) that is associated with dysregulation of Central Nervous System (CNS) and Autonomic Nervous System (ANS). The current session on clinical neurology and pain focuses on: Neurological conditions affecting people and treatment of neurological or personality disorders, Post stroke pain, Diagnostic procedure for neuropathic pain and Biomarkers` Investigation.

Related Conferences of Clinical Neurology and Neuropathic pain

5th World Congress on Neurology and Therapeutics, March 14-16, 2016 London, UK, Global Neuroscience Conference, November 07-09, 2016 Melborne, Australia, 6thGlobal Neurologists Annual Meeting onNeurology and Neuro Surgery, August 01-03, 2016 Frankfurt, Germany, International Conference on Neurorehabilitation, July 21-22, 2016 Brisbane, Australia, 2nd International Conference on Neurological Disorders and Stroke, April 28-30, 2016 Dubai, UAE, 6th World Neurological Conference May 19-21, 2016 San Antonio, USA,9th International Symposium on Neuroprotection and Neurorepair 2016,Germany, 10th FENS Forum of Neuroscience 2016, Copenhagen, Denmark, Society for Neuroscience 2016 Annual, California, USA, EANS2016: , 5th Euro-CNSBasic Course in Neuropathology, 12th Annual Update Conference on Clinical Neurology & Neurophysiology, Tel Aviv-Yafo, Israel. Vienna Neuro & Orthopaedic MRI Workshop, Vienna, Austria.

Track 13: Market Analysis of Neuro Therapeutics

The market analysis of neurotherapeutics represent the largest and untapped market in medicine sector. This estimated market analysis is based on probability of approval and sales of products in late stage development, demographic trends and marketing of product. Emerging markets once again helps to boost revenues. CNS therapeutics comprise approximately 15% of total pharmaceutical sales, nearly $30 billion worldwide. An estimated annual economic costs of anxiety disorders, depression, and schizophrenia are $47 billion, $44 billion, and $33 billion per year approximately. The success rates for neurotherapeutics, are far lower than average. Decline in success rates late in development hugely accelerate the financial risk of development in Neuro therapeutics. Neural disorders such as , multiple sclerosis, epilepsy and Parkinsons disease inflict great pain and suffering on patients, and every year costs the U.S. economy billions of dollars. Industraial advancenments in biopharmaceutical research companies are developing 444 new medicines to prevent and treat neurological diseases which include: 82 medicines for Alzheimers disease, 82 medicines for pain, 62 medicines for brain tumors. 38 medicines for multiple sclerosis, 28 medicines for epilepsy and seizures, 27 medicines for Parkinsons disease, For headache 25 medicines , including migraines, thereby focusing utmost importance in the field of drug research for neurological disorders and Drug Development, Current Clinical Research, Market Value and Growth of Drugs.

Related Conferences of Neuro Therapeutics

5th World Congress on Neurology and Therapeutics, March 14-16, 2016 London, UK, Global Neuroscience Conference, November 07-09, 2016 Melborne, Australia, 6thGlobal Neurologists Annual Meeting onNeurology and Neuro Surgery, August 01-03, 2016 Frankfurt, Germany, International Conference on Neurorehabilitation, July 21-22, 2016 Brisbane, Australia, 2nd International Conference on Neurological Disorders and Stroke, April 28-30, 2016 Dubai, UAE, 6th World Neurological Conference May 19-21, 2016 San Antonio, USA,9th International Symposium on Neuroprotection and Neurorepair 2016,Germany, 10th FENS Forum of Neuroscience 2016, Copenhagen, Denmark, Society for Neuroscience 2016 Annual, California, USA, EANS2016: , 5th Euro-CNSBasic Course in Neuropathology, 12th Annual Update Conference on Clinical Neurology & Neurophysiology, Tel Aviv-Yafo, Israel.

Read the original post:
Neurology Conference | Neurology Congress | Neuroscience ...

Neurology – Wikipedia, the free encyclopedia

Posted on by

Neurology (from Greek: , neuron, and the suffix - -logia "study of") is a branch of medicine dealing with disorders of the nervous system. Neurology deals with the diagnosis and treatment of all categories of conditions and disease involving the central and peripheral nervous system (and its subdivisions, the autonomic nervous system and the somatic nervous system); including their coverings, blood vessels, and all effector tissue, such as muscle.[1] Neurological practice relies heavily on the field of neuroscience, which is the scientific study of the nervous system.

A neurologist is a physician specializing in neurology and trained to investigate, or diagnose and treat neurological disorders.[2] Neurologists may also be involved in clinical research, clinical trials, and basic or translational research. While neurology is a non-surgical specialty, its corresponding surgical specialty is neurosurgery.[2]

A large number of neurological disorders have been described. These can affect the central nervous system (brain and spinal cord), the peripheral nervous system, the autonomic nervous system and the muscular system.

Occupation type

Activity sectors

Education required

Many neurologists also have additional training or interest in one area of neurology, such as stroke, epilepsy, neuromuscular, sleep medicine, pain management, or movement disorders.

In the United States and Canada, neurologists are physicians having completed postgraduate training in neurology after graduation from medical school. Neurologists complete, on average, at least 1013 years of college education and clinical training. This training includes obtaining a four-year undergraduate degree, a medical degree (D.O. or M.D.), which comprises an additional four years of study, and then completing a one-year internship and a three- or four-year residency in neurology.[6] The four-year residency consists of one year of internal medicine training followed by three years of training in neurology.

Some neurologists receive additional subspecialty training focusing on a particular area of neurology. These training programs are called fellowships, and are one to two years in duration. Sub-specialties include: brain injury medicine, clinical neurophysiology, epilepsy, hospice and palliative medicine, neurodevelopmental disabilities, neuromuscular medicine, pain medicine and sleep medicine, vascular neurology (stroke),[7]behavioral neurology, child neurology, headache, multiple sclerosis, neuroimaging, neurorehabilitation, and interventional neurology.

In Germany, a compulsory year of psychiatry must be done to complete a residency of neurology.

Read the original here:
Neurology - Wikipedia, the free encyclopedia

Neurology | University of Michigan, Ann Arbor

Posted on by

Welcome: A Message from Dr. Fink, Chair

The brain makes us who we are, largely defining our uniqueness as individuals and as a species. For this reason diseases that attack the nervous system - whether suddenly as in stroke, insidiously as in Alzheimer's disease, or with recurrent attacks as may occur in multiple sclerosis - strike at the core of our being. Imagine being unable to speak, being unable to move your limbs at will, or experiencing difficulty recognizing common surroundings or close relatives.

In the Department of Neurology at the University of Michigan, a dedicated team of academic neurologists pursues the three-part academic mission of clinical care, research and education. Highly skilled physicians with subspecialty expertise in each of the domains of adult neurology provide care to patients with diseases of the nervous system in both hospital and outpatient settings. Many of these physicians direct laboratory or clinical research programs to advance our understanding of neurological disease, and to develop and test new therapies for these diseases.

David J. Fink, M.D.Robert Brear Professor and Chair

Link:
Neurology | University of Michigan, Ann Arbor